Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration (Q39008341)

8 September 2017

title

Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration (English)

1 reference

8 September 2017

4

Carlo Caltagirone

1 reference

8 September 2017

2

Aleksander A Mathé

1 reference

8 September 2017

Nicoletta Croce

1

1 reference

8 September 2017

Francesca Gelfo

series ordinal

3

1 reference

8 September 2017

Sergio Bernardini

series ordinal

5

1 reference

8 September 2017

Francesco Angelucci

series ordinal

6

1 reference

8 September 2017

language of work or name

English

0 references

publication date

2 April 2014

1 reference

Journal of Psychopharmacology

8 September 2017

published in

1 reference

8 September 2017

volume

28

1 reference

8 September 2017

issue

10

1 reference

8 September 2017

page(s)

964-972

1 reference

Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Neurotrophins, synaptic plasticity and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Effect of mood stabilizers on DNA methylation in human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Brain Derived Neurotrophic Factor: a novel neurotrophin involved in psychiatric and neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Role of the brain-derived neurotrophic factor at glutamatergic synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Interpreting magnetic resonance imaging findings in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Manic episodes are associated with grey matter volume reduction - a voxel-based morphometry brain analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Neuroregeneration in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Dysfunctional hippocampal activity affects emotion and cognition in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Recovery of learning and memory is associated with chromatin remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Does lithium prevent Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Illness duration and total brain gray matter in bipolar disorder: evidence for neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Chronic inhibition of glycogen synthase kinase-3 protects against rotenone-induced cell death in human neuron-like cells by increasing BDNF secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Decreased serum brain-derived neurotrophic factor levels in major depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Meta-analysis, Database, and Meta-regression of 98 Structural Imaging Studies in Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

A Functional Role for CREB as a Positive Regulator of Memory Formation and LTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Neuroprotective effects of psychotropic drugs in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Polytherapy in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Valproic acid improves locomotion in vivo after SCI and axonal growth of neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

The cellular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Potential therapeutic uses of BDNF in neurological and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Divergent effects of lithium and sodium valproate on brain-derived neurotrophic factor (BDNF) production in human astrocytoma cells at therapeutic concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Neuroprotective effect of chronic lithium treatment against hypoxia in specific brain regions with upregulation of cAMP response element binding protein and brain-derived neurotrophic factor but not nerve growth factor: comparison with acute lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Cell pathology in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Excellent lithium responders have normal cognitive functions and plasma BDNF levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

The neurotrophin hypothesis for synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Serum brain-derived neurotrophic factor in euthymic bipolar patients on prophylactic lithium therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Pathophysiological mechanisms for actions of the neurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

MeCP2 deficiency downregulates specific nuclear proteins that could be partially recovered by valproic acid in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Lithium and valproate protect hippocampal slices against ATP-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

Comprehensive algorithm for quantitative real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881114529379

21 January 2018

Identifiers

DOI

10.1177/0269881114529379

1 reference

8 September 2017

1 reference